4549 Eiken Kagaku
- Japan Guru
- Jul 5, 2025
- 1 min read
A major clinical diagnostics company. Has 70% market share in fecal occult blood test reagents (FIT). Also developing urine tests and genetic tests.
top of page
No.1 English-language social media platform for Japanese stocks
Powered by Japan Guru
4 Comments
bottom of page
https://x.com/maron_fine/status/1941403732576698407
https://x.com/26ooo/status/1937998286285406360
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://ssl4.eir-parts.net/doc/4549/ir_material1/251720/00.pdf
Dalton and affiliates together hold 27%, increasing stake as recently as May 27
Shareholder proposal just passed in June to enable shareholders to decide dividend via shareholder meetings
Coupled with JP Govt push to solve "cash hoarding" issue, the management hands are probably completely tied and would have no choice but to pay out dividends on consistent basis
https://x.com/japan_guru_x/status/1939824446606606529
at 2080/share, 80 bil yen mkt cap vs 16 bil yen net cash
18.43x per / 1.61x pbr / 2.79% dividend